ResearcherYale UniversityNo recent work listed
Mark S. Kidd
Matched on ORCID iD 0000-0002-1525-5167; OpenAlex author ID A5009119423. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2011: 1 paper · 2012: none · 2013: none · 2014: 1 paper · 2015: 2 papers · 2016: none · 2017: 1 paper
Papers 5
- Aspirin Use and Reduced Risk of Pancreatic Cancer. Co-author DOI 10.1158/1055-9965.epi-16-0508↗
- Risch et al. Respond to "Clinical Utility of Prediction Models for Rare Outcomes: The Example of Pancreatic Cancer". Last author DOI 10.1093/aje/kwv025↗
- Detectable Symptomatology Preceding the Diagnosis of Pancreatic Cancer and Absolute Risk of Pancreatic Cancer Diagnosis. Last author DOI 10.1093/aje/kwv026↗
- Case-control study of aspirin use and risk of pancreatic cancer. Co-author DOI 10.1158/1055-9965.epi-13-1284↗
- Genetic effects and modifiers of radiotherapy and chemotherapy on survival in pancreatic cancer. Co-author DOI 10.1097/mpa.0b013e31821268d1↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Herbert Yu · 5 shared papers, 2011–2017 · strength 0.30
- Paper Risch et al. Respond to "Clinical Utility of Prediction Models for Rare Outcomes: The Example of Pancreatic Cancer". DOI 10.1093/aje/kwv025↗
- Paper Detectable Symptomatology Preceding the Diagnosis of Pancreatic Cancer and Absolute Risk of Pancreatic Cancer Diagnosis. DOI 10.1093/aje/kwv026↗
- Paper Aspirin Use and Reduced Risk of Pancreatic Cancer. DOI 10.1158/1055-9965.epi-16-0508↗
- Harvey A. Risch Risch · 5 shared papers, 2011–2017 · strength 0.30
- Paper Risch et al. Respond to "Clinical Utility of Prediction Models for Rare Outcomes: The Example of Pancreatic Cancer". DOI 10.1093/aje/kwv025↗
- Paper Detectable Symptomatology Preceding the Diagnosis of Pancreatic Cancer and Absolute Risk of Pancreatic Cancer Diagnosis. DOI 10.1093/aje/kwv026↗
- Paper Aspirin Use and Reduced Risk of Pancreatic Cancer. DOI 10.1158/1055-9965.epi-16-0508↗
- Lingeng Lu · 5 shared papers, 2011–2017 · strength 0.30
- Paper Risch et al. Respond to "Clinical Utility of Prediction Models for Rare Outcomes: The Example of Pancreatic Cancer". DOI 10.1093/aje/kwv025↗
- Paper Detectable Symptomatology Preceding the Diagnosis of Pancreatic Cancer and Absolute Risk of Pancreatic Cancer Diagnosis. DOI 10.1093/aje/kwv026↗
- Paper Aspirin Use and Reduced Risk of Pancreatic Cancer. DOI 10.1158/1055-9965.epi-16-0508↗
- Samantha A. Streicher · 2 shared papers, 2014–2017 · strength 0.12
- Yu-Tang Gao · 1 shared paper, 2017 · strength 0.07
- Quanxing Ni · 1 shared paper, 2017 · strength 0.07
- Hongmei Zeng · 1 shared paper, 2011 · strength 0.03
- Muhammad Wasif Saif · 1 shared paper, 2011 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.